This complementary and alternative medicine (CAM) information summary provides an overview of the use of antineoplastons as treatments for people with cancer. The summary includes a brief history of the development of antineoplastons; a review of laboratory, animal, and human studies; and possible side effects associated with antineoplaston use.
This summary contains the following key information:
Antineoplastons are drugs composed of chemical compounds that are naturally present in the urine...
Table 2, Genes Associated with a High Susceptibility of Colorectal Cancer, was extensively revised.
Major Genetic Syndromes
Added text to state that in patients with Peutz-Jeghers syndrome, the cumulative risks have been estimated to be 32% to 54% for breast cancer and 21% for ovarian cancer.
The Juvenile polyposis syndrome (JPS) subsection was comprehensively reviewed and extensively revised.
The CHEK2 subsection was comprehensively reviewed and extensively revised.
The Hereditary mixed polyposis syndrome subsection was comprehensively reviewed and revised.
The Serrated polyposis syndrome/Hyperplastic polyposis syndrome subsection was comprehensively reviewed and extensively revised.
Revised Table 12, Published Recommendations for Diagnosis and Surveillance of JPS, to include text about an additional study (cited Latchford et al. as reference 448).
This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.
In this article
This information is produced and provided by the National
Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National
Institute via the Internet web site at http://
.gov or call 1-800-4-CANCER.
WebMD Public Information from the National Cancer Institute
September 04, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this